Company / PP&E (Net)
Nuo Therapeutics, Inc. PP&E (Net) History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$223.6K
FY2017
5-year range
$223.6K / $1.1M
FY2013-FY2017
Trend
-54.0%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $1M to $223,616 over the past 2 years.
Based on SEC 10-K filings.
$223,616 in FY2017 with a 3-year CAGR of -37.7%.
Declined from $1M to $223,616 over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -37.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -37.7%, indicating a declining trend.
- In FY2017, pp&e (net) decreased 54.0% year-over-year.
- Peak pp&e (net) was recorded in FY2015.
Company context
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2017 | $223.6K | -54.0% |
| FY2016 | $486.1K | -56.4% |
| FY2015 | $1.1M | +20.5% |
| FY2014 | $925.2K | +0.6% |
| FY2013 | $919.5K | - |
| FY2012 | - | - |
| FY2011 | $978.9K | - |
As of FY2017 · SEC 10-K · Updated Jun 29, 2026